Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism

Jim C. Hu, Stephen B. Williams, A. James O'Malley, Matthew R. Smith, Paul L. Nguyen, Nancy L. Keating

Research output: Contribution to journal › Article › peer-review

89 Scopus citations

Fingerprint

Dive into the research topics of 'Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism'. Together they form a unique fingerprint.

Medicine & Life Sciences